Free Trial

Brad Brubaker Sells 66,665 Shares of UiPath (NYSE:PATH) Stock

UiPath logo with Computer and Technology background

Key Points

  • Brad Brubaker, an insider at UiPath, sold **66,665 shares** at an average price of **$15.00**, totaling approximately **$999,975**, reducing his position by **8.80%** to **690,519 shares**.
  • UiPath reported **$0.15 earnings per share (EPS)** for its last quarter, surpassing estimates of **$0.08** and showing a **14.6% year-over-year revenue increase** to **$361.73 million**.
  • Analysts have varied ratings for UiPath, with a consensus rating of **"Hold"** and a target price averaging **$13.21**, reflecting mixed views on the stock's future performance.
  • Interested in UiPath? Here are five stocks we like better.

UiPath, Inc. (NYSE:PATH - Get Free Report) insider Brad Brubaker sold 66,665 shares of UiPath stock in a transaction on Monday, October 6th. The shares were sold at an average price of $15.00, for a total value of $999,975.00. Following the sale, the insider directly owned 690,519 shares of the company's stock, valued at approximately $10,357,785. The trade was a 8.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Brad Brubaker also recently made the following trade(s):

  • On Tuesday, September 30th, Brad Brubaker sold 16,083 shares of UiPath stock. The shares were sold at an average price of $15.00, for a total value of $241,245.00.

UiPath Stock Performance

Shares of UiPath stock traded up $1.61 during trading on Monday, hitting $14.51. 60,922,831 shares of the stock traded hands, compared to its average volume of 12,752,335. The stock has a market cap of $7.71 billion, a P/E ratio of 483.67, a PEG ratio of 4.77 and a beta of 1.07. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $15.93. The company has a fifty day moving average price of $11.57 and a two-hundred day moving average price of $11.86.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.07. The business had revenue of $361.73 million during the quarter, compared to analyst estimates of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The firm's revenue was up 14.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.04 EPS. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities research analysts expect that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on PATH. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research note on Friday, September 5th. Canaccord Genuity Group reduced their price target on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Monday, September 8th. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday, September 6th. BMO Capital Markets boosted their price target on UiPath from $12.50 to $13.00 and gave the stock a "market perform" rating in a research report on Thursday. Finally, Weiss Ratings restated a "sell (d)" rating on shares of UiPath in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, UiPath currently has a consensus rating of "Hold" and a consensus target price of $13.21.

Get Our Latest Report on UiPath

Hedge Funds Weigh In On UiPath

Several large investors have recently made changes to their positions in PATH. GAMMA Investing LLC lifted its position in shares of UiPath by 1,207.7% during the 1st quarter. GAMMA Investing LLC now owns 20,806 shares of the company's stock worth $2,020,000 after purchasing an additional 19,215 shares during the last quarter. Merit Financial Group LLC lifted its holdings in shares of UiPath by 31.7% during the first quarter. Merit Financial Group LLC now owns 64,648 shares of the company's stock worth $666,000 after buying an additional 15,543 shares during the last quarter. Washington Capital Management Inc. lifted its holdings in shares of UiPath by 23.5% during the first quarter. Washington Capital Management Inc. now owns 42,000 shares of the company's stock worth $433,000 after buying an additional 8,000 shares during the last quarter. Pallas Capital Advisors LLC lifted its holdings in shares of UiPath by 32.2% during the first quarter. Pallas Capital Advisors LLC now owns 84,776 shares of the company's stock worth $873,000 after buying an additional 20,667 shares during the last quarter. Finally, CX Institutional acquired a new position in shares of UiPath during the first quarter worth approximately $36,000. Institutional investors and hedge funds own 62.50% of the company's stock.

About UiPath

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.